That though did run through my head "another mouth to feed" but then I said maybe I had better not post that and give the man a chance to see what he can deliver.
After reading the item on AYTU and Zolpimist I keep asking myself why haven't SUDA at least submitted a MAA for it in Australia.
Can you imagine what our share price might do if they could get a MAA for Zolpimist here in Australia, even if either TEVA or Eddingpharm coud get approval in their licensed Territories.
We need to get one of our products approved and commercialised and revenue flowing in, we also need regular updates on just how the number of discussions with so called big pharmas are actually progressing.
Why have we not heard about the 21 June 2017 with the MHRA
"The proposed regulatory dossier is intended to support a marketing authorisationapplication to either the MHRA or the European Medicines Agency. Furthermore, SUDAwill be seeking advice from the MHRA on the acceptability of the excipients used in theZolpiMist oral spray formulation which are all listed in the US pharmacopeia."
So maybe this impressive team you state SUDA are building will somehow get things moving.
SUD Price at posting:
0.4¢ Sentiment: Hold Disclosure: Held
